Alpha Teknova, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Alpha Teknova, Inc. | TKNO - NASDAQ |
$14.00-$16.00 | $16.00 | $20.72 | 6 million | 6/25/2021 |
| Cowen, William Blair | ||||||
Co-Manager(s): BTIG, Stephens Inc. | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-04 Terms Added 2021-06-21 | ||||||
Alpha Teknova, Inc. Quote & Chart - Click for current quote - TKNO
IPO Boutique aggregates information on public companies and private companies, such as "TKNO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Alpha Teknova, Inc. (adapted from Alpha Teknova, Inc. prospectus):
They are a leading provider of critical reagents that enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading provider of critical reagents that enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TKNO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.